Tuesday 7 July 2015

Summer Briefing 2015 Published

We are pleased to release the latest briefing from the Centre for Business Innovation in Cambridge UK. It describes our international consortia for:

- corporate venturing
- social media for business
- microfluidics
- nano-carbon enhanced materials
- open innovation meets big data
- medical adherence
- inclusive design

which are helping some of the world's best companies leverage each others position and insight to do more with less.

Read about it here

Thursday 11 June 2015

New Annual Cycle of the Social Media for Business Consortium

CfBI is about to launch its second Social Media for Business Consortium.

Building on the success of the first consortium which attracted blue chip organisations from across Europe, the consortium provides a confidential, trusting  environment for users of social media to benchmark and compare notes on what works and what not as they seek to apply Social Media in new ways to new KPIs .. all this away from the attention of vendors, consultants and competitors.

The consortium is shaped by the consensus of  needs of  its members. For a confidential discussion about possible win-wins for your organisation, please contact emmanuel.carraud@cfbi.com

CfBI mulls a new consortium around "Corporate Venturing"

CfBI is currently in discussion with its members about the creation and format of a new consortium focussed on Corporate Venturing.

This consortium would draw on the tried and tested format of the other six consortia which we run. It is designed for corporate executives tasked with leveraging relationships between large and small companies.

Covering : Incubation, Competitions, Spin-outs/ins as well as traditional M&A this private trusting group will seek to leverage each others' experience (bad as well as good) in Corporate Venturing 2.0

If you are interested in finding out more, please contact adam.swash@cfbi.com

FDA Keynote at Microfluidics Consortium Open Day in Boston June 25

The MF6 Microfluidics consortium is delighted to have won a keynote address from Yun-Fu Hu , deputy director of the FDA at the consortium's open day in Boston on June 25th.

Dr Hu will be leading a Q & A session afterwards around opportunities to accelerate the uptake of microfluidics innnovation in healthcare applications such as diagnostics, screening, genomics and regenerative medicine.

For details and registration please visit http://www.cfbi.com/mf55landingpage.htm (and refresh your browser to get the latest version of these regularly changing pages)

Friday 10 April 2015

Open Innovation meets Big Data Consortium meeting in London

On April 28/29th hosted by the new Ordnance Survey Innovation Centre, CfBI's Open Innovation meets Big Data consortium will be working applying its thinking about trading data rich assets B2B to 'Future Retail'

With expert witnesses from retail and FMCG though leaders across Europe the session will be held under Chatham House Rule.

Details from ceo@cfbi.com

Friday 13 March 2015

MF6 Microfluidics Consortium visits Copenhagen and Boston

MF6 Microfluidics Consortium visits Copenhagen and Boston

On Apr 23rd and 24th the MF6 microfluidics consortium will be in Copenhagen - kindly hosted by its members Radiometer and DTU. Consortium members will be working on research, commercial uptake and a number of EU initiatives as well as visiting two production facilities.

On June 24th and 25th the MF6 microfluidics consortium will be in Boston - kindly hosted by Microsoft Research and the British Consulate. On June 25th we are having an open day where non-members can attend and be inspired by talks and demonstrations from consortium members.

Did you know that…
  • Up to 50% of patients do not take their prescribed medication?
  • Up to 10% of all hospital admissions are due to medication-related problems including those caused by drugs not being taken, or being taken incorrectly?
  • That the cost of patients not following their prescribed treatment regime correctly is estimated to cost health care systems around the world over $300bn annually?
The term used to describe the correct taking of a prescribed course of medical treatment is ‘medical adherence’. Poor medical adherence is a big problem – described by the WHO as ‘a worldwide problem of striking magnitude’.
The Centre for Business Innovation Medical Adherence Consortium is a group of organisations all of whom have an interest in the problem of poor medical adherence and a shared belief that technology might be a part of the solution. This group met for the first time at BUPA House in London towards the end of February. Organisations as diverse as BUPA, GlaxoSmithKline, AbbVie, Tunstall, Janssen, Proteus Digital Health, NICE and others discussed the key areas that need to be addressed if progress is to be made in this difficult area.
The group identified areas where common obstacles to improving poor adherence are thought to lie including:
  • Economic / financial considerations: ensuring that good adherence makes economic sense for all actors.
  • Standardisation: agreement around terminology, identification of gaps in information and other standards and planning to address these.
  • Regulation: identification of key obstacles to improved adherence associated with regulation and determine the best way of engaging with the regulator to jointly determine if and how these might be addressed.
  • "Case studies": identification and dissemination of success stories to encourage wider engagement with the subject of adherence.
  • Measurement / data: understanding problems around measurement of adherence, identifying and disseminating baseline measurements, agreeing standard approaches to measurement.
  • Sustainability: ensuring that any adherence approaches are not only affordable but are sustainable for the long term.

Future meetings will develop these themes and look to make concrete progress in each of them – helping to address some of the problems preventing progress in the difficult area of medical adherence.

Sunday 18 January 2015

CfBI's New Year Briefing now available

Visit http://www.cfbi.com/CfBIBriefingNY2015.pdf to download the latest edition of CfBI's briefing with details of its achievements in the 2nd half of 2014 as well as cameo descriptions of all its active consortia

Medical Adherence Consortium Launches Feb 25th

The Centre for Business Innovation is delighted to announce that its latest pan-industry consortium 'Medical Adherence' launches on February 25th in London.

Shaped by input from its founders including: NICE, Abbvie, BUPA, GSK and Philips the first meeting of the consortium will be hosted by BUPA at their London Headquarters.

Dr Jeremy Holland who leads the consortium tells us "Medical Adherence is the problem arising because patients do not follow their doctors' advice in taking medication or making lifestyle changes. It costs the industry $trillions and ruins patients lives".

Dr Peter Hewkin for CfBI adds "This is exactly the type of problem where CfBI's consortium approach is most appropriate to address - bringing together stakeholders from diverse industries to find a shared view of how to get market traction for new classes of solution."

The consortium members come form across Europe - but take a global view on the nature of the problem and how it might best be addressed.

CfBI is a neutral facilitator - which does not hold IP or sell consultancy. It runs 5 other consortia using the same process and has a long track record of success